Harborview Medical Center Investigational Drug Services — Seattle, Washington

Harborview Medical Center Investigational Drug Services is a clinical research site located in Seattle, Washington, United States 98104.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Harborview Medical Center Investigational Drug Services has participated in 2 clinical trials.

Therapeutic areas: Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis With Liver Fibrosis, Non-alcoholic Steatohepatitis.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Harborview Medical Center Investigational Drug Services?

Harborview Medical Center Investigational Drug Services has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Harborview Medical Center Investigational Drug Services conducted?

Harborview Medical Center Investigational Drug Services has 2 clinical trials on record. Their work covers Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis With Liver Fibrosis, Non-alcoholic Steatohepatitis.

Is Harborview Medical Center Investigational Drug Services accredited by Crixeo Health?

Harborview Medical Center Investigational Drug Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Harborview Medical Center Investigational Drug Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.